- Antiviral Therapy in Hepatitis B Carriers Undergoing Immunosuppressive Treatment or Cytotoxic Chemotherapy
-
Yoon JH
- KMID: 760574
- Korean J Hepatol.
- 2005 Mar;11(1):17-20.
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Hepatitis C virus infection in patients with hemophilia in Korea: Is antiviral therapy effective and safe?
-
Rou WS, Lee BS
- KMID: 2164361
- Clin Mol Hepatol.
- 2015 Jun;21(2):122-124.
- doi: 10.3350/cmh.2015.21.2.122
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Comparison of Efficacy of Peginterferon and Ribavirin Combination Therapy for Chronic Hepatitis C among Korean, Caucasian and Other Asians
-
Kim KA
- KMID: 1775791
- Korean J Gastroenterol.
- 2012 Nov;60(5):273-274.
- doi: 10.4166/kjg.2012.60.5.273
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Hope for Cirrhosis Patients with Genotype 1 Hepatitis C Virus Who Failed the Previous Treatment
-
Kwon JH
- KMID: 2373327
- Korean J Gastroenterol.
- 2015 Aug;66(2):131-133.
- doi: 10.4166/kjg.2015.66.2.131
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Durability of antiviral therapy for chronic hepatitis C after achieving sustained virological response
-
Heo J
- KMID: 1025196
- Korean J Hepatol.
- 2011 Sep;17(3):180-182.
- doi: 10.3350/kjhep.2011.17.3.180
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- The Cumulative Colectomy Rate in Patients with Cytomegalovirus-Positive Ulcerative Colitis
-
Ozturk K, Demirci H, Kantarcioglu M, Uygun A, Bagci S
- KMID: 2380773
- Gut Liver.
- 2015 Mar;9(2):253-253.
- doi: 10.5009/gnl14450
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Is peginterferon and ribavirin therapy effective in Korean patients with chronic hepatitis C?
-
Jung YK, Kim JH
- KMID: 1493571
- Clin Mol Hepatol.
- 2013 Mar;19(1):26-28.
- doi: 10.3350/cmh.2013.19.1.26
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Is HBsAg Loss an Ideal End-point of Oral Antiviral Therapy in Chronic Hepatitis B Patients?
-
Kang K, Kim JH
- KMID: 2155334
- Korean J Gastroenterol.
- 2014 May;63(5):329-332.
- doi: 10.4166/kjg.2014.63.5.329
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- HBV Mutations During Antiviral Therapy in Patients with Chronic Hepatits B
-
Hwang SG
- KMID: 1119357
- Korean J Hepatol.
- 2005 Dec;11(4):311-319.
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Reply: Careful Assessment Is Needed in Patients with Ulcerative Colitis with Evidence of Cytomegalovirus Reactivation
-
Kim YS, Kim JS
- KMID: 2380774
- Gut Liver.
- 2015 Mar;9(2):254-255.
- doi: 10.5009/gnl14501
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Is tenofovir disoproxil fumarate an all-powerful weapon in the treatment of chronic hepatitis B?
-
Kim JH, Lee JS
- KMID: 2129658
- Korean J Intern Med.
- 2015 Jan;30(1):23-26.
- doi: 10.3904/kjim.2015.30.1.23
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Renewed 2015 Clinical Practice Guidelines for Management of Hepatitis C by Korean Association for the Study of the Liver; What Has Been Changed? - Treatment of Patients with Decompensated Cirrhosis
-
Gwak GY
- KMID: 2373413
- Korean J Gastroenterol.
- 2016 Mar;67(3):137-141.
- doi: 10.4166/kjg.2016.67.3.137
HCV-related decompensated liver cirrhosis is a life-threatening illness with an average 5-year survival rate of 50%. Because these patients have higher risk of morbidity and mortality including development of hepatocellular... -
- CITED
-
- Close
- SHARE
-
- Close
- Therapy with Direct-Acting Antiviral Agents for Hepatitis C-Related Liver Cirrhosis
-
Toshikuni
- KMID: 2412206
- Gut Liver.
- 2017 May;11(3):335-348.
- doi: 10.5009/gnl15458
Chronic hepatitis C virus (HCV) infection may eventually lead to liver cirrhosis (LC), a condition associated with a high risk of liver failure and hepatocellular carcinoma. Although interferon (IFN)-based therapy... -
- CITED
-
- Close
- SHARE
-
- Close
- Letter to the Editor: Should We Really Take Anti-Viral Therapy into Account in Chronic Hepatitis B Patients with Normal Liver Function?
-
Khosravi M, Alavian SM
- KMID: 2373686
- J Korean Med Sci.
- 2016 May;31(5):824-824.
- doi: 10.3346/jkms.2016.31.5.824
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Renewed 2015 Clinical Practice Guidelines for Management of Hepatitis C by Korean Association for the Study of the Liver; What Has Been Changed? - Treatment of Chronic Hepatitis C Genotype 2 and 3
-
Jung YK
- KMID: 2373412
- Korean J Gastroenterol.
- 2016 Mar;67(3):132-136.
- doi: 10.4166/kjg.2016.67.3.132
Ever since direct-acting antiviral agents (DAA) have been approved and released into the world, numerous studies on the efficacy, adverse effects and drug-drug interactions of interferon-free DAA combination therapy have... -
- CITED
-
- Close
- SHARE
-
- Close
- Impact of ribavirin dose reduction during treatment in chronic hepatitis C genotype 1 patients
-
Chung WJ
- KMID: 1392905
- Clin Mol Hepatol.
- 2012 Sep;18(3):268-271.
- doi: 10.3350/cmh.2012.18.3.268
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Current Antiviral Therapy for Chronic Hepatitis B
-
Lim YS, Suh DJ
- KMID: 2157673
- J Korean Med Sci.
- 2004 Aug;19(4):489-494.
- doi: 10.3346/jkms.2004.19.4.489
During the past decade, major breakthroughs have been achieved in treatment of chronic hepatitis B. Currently, three therapeutic agents are approved for chronic hepatitis B: interferon-alpha, lamivudine and adefovir dipivoxil.... -
- CITED
-
- Close
- SHARE
-
- Close
- Renewed 2015 Clinical Practice Guidelines for Management of Hepatitis C by Korean Association for the Study of the Liver; What Has Been Changed? - Treatment of Chronic Hepatitis C Genotype 1
-
Park SH
- KMID: 2373411
- Korean J Gastroenterol.
- 2016 Mar;67(3):127-131.
- doi: 10.4166/kjg.2016.67.3.127
The introduction of direct-acting antiviral agents (DAAs) has markedly improved the sustained virological response (SVR) rates in patients with chronic hepatitis C. Currently, four classes of DAAs targeting three HCV... -
- CITED
-
- Close
- SHARE
-
- Close
- Monitoring and Treatment Strategy for Chronic Hepatitis B and Antiviral Resistant Hepatitis B
-
Kim TY, Sohn JH
- KMID: 782870
- Korean J Gastroenterol.
- 2007 Jun;49(6):346-355.
Clinical management of chronic hepatitis B is rapidly evolving after the recent development of new antiviral drugs. These agents have been shown to be effective in improving virological, biochemical, and... -
- CITED
-
- Close
- SHARE
-
- Close
- Management of Chronic Hepatitis B in Treatment-Naive Patients
-
Cheong JY
- KMID: 1767538
- Korean J Gastroenterol.
- 2008 Jun;51(6):338-345.
Chronic hepatitis B (CHB) is a serious health problem in Korea. The natural history of chronic HBV infection has been divided into 4 phases: immune tolerance, immune clearance, inactive HBsAg... -
- CITED
-
- Close
- SHARE
-
- Close
